Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 148141000001117 | Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 148151000001119 | Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only | true | Inferred relationship | Existential restriction modifier | ||
| Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) | Is a | Daunorubicin 44mg / Cytarabine 100mg powder for concentrate for solution for infusion vials | true | Inferred relationship | Existential restriction modifier | ||
| Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) | Has specific active ingredient | Daunorubicin | true | Inferred relationship | Existential restriction modifier | ||
| Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) | Has specific active ingredient | Cytarabine | true | Inferred relationship | Existential restriction modifier | ||
| Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) | Has dispensed dose form | Powder for conventional release solution for infusion | true | Inferred relationship | Existential restriction modifier | ||
| Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) | Is a | Actual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) | Is a | Vyxeos | true | Inferred relationship | Existential restriction modifier | ||
| Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) | Has active ingredient | Daunorubicin | true | Inferred relationship | Existential restriction modifier | ||
| Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) | Has active ingredient | Cytarabine | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) 1 vial | Has AMP | True | Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR